Bank of Montreal’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-20,432
| Closed | -$80K | – | 3480 |
|
|
2021
Q3 | $80K | Hold |
20,432
| – | – | ﹤0.01% | 3280 |
|
|
2021
Q2 | $83K | Sell |
20,432
-897
| -4% | -$3.64K | ﹤0.01% | 3223 |
|
|
2021
Q1 | $53K | Buy |
21,329
+15,606
| +273% | +$38.8K | ﹤0.01% | 3279 |
|
|
2020
Q4 | $12K | Buy |
5,723
+3,903
| +214% | +$8.18K | ﹤0.01% | 4125 |
|
|
2020
Q3 | $5K | Sell |
1,820
-1,179
| -39% | -$3.24K | ﹤0.01% | 4000 |
|
|
2020
Q2 | $8K | Buy |
2,999
+2,899
| +2,899% | +$7.73K | ﹤0.01% | 3897 |
|
|
2020
Q1 | $0 | Sell |
100
-90,160
| -100% | – | ﹤0.01% | 3892 |
|
|
2019
Q4 | $258K | Buy |
90,260
+1,447
| +2% | +$4.14K | ﹤0.01% | 2556 |
|
|
2019
Q3 | $326K | Buy |
88,813
+78,721
| +780% | +$289K | ﹤0.01% | 2226 |
|
|
2019
Q2 | $42K | Sell |
10,092
-92,408
| -90% | -$385K | ﹤0.01% | 3322 |
|
|
2019
Q1 | $524K | Sell |
102,500
-209,100
| -67% | -$1.07M | ﹤0.01% | 1959 |
|
|
2018
Q4 | $1.07M | Buy |
311,600
+145,100
| +87% | +$498K | ﹤0.01% | 1666 |
|
|
2018
Q3 | $1M | Buy |
166,500
+91,000
| +121% | +$547K | ﹤0.01% | 1803 |
|
|
2018
Q2 | $480K | Buy |
+75,500
| New | +$480K | ﹤0.01% | 2119 |
|
|
2016
Q2 | – | Sell |
-100
| Closed | – | – | 3840 |
|
|
2016
Q1 | $0 | Hold |
100
| – | – | ﹤0.01% | 3952 |
|
|
2015
Q4 | $0 | Hold |
100
| – | – | ﹤0.01% | 4020 |
|
|
2015
Q3 | $0 | Hold |
100
| – | – | ﹤0.01% | 3767 |
|
|
2015
Q2 | $0 | Hold |
100
| – | – | ﹤0.01% | 3729 |
|
|
2015
Q1 | $0 | Hold |
100
| – | – | ﹤0.01% | 3743 |
|
|
2014
Q4 | $0 | Buy |
+100
| New | – | ﹤0.01% | 3631 |
|